| Autor: |
Arlette JP; 70401 Department of Surgery, Cumming School of Medicine, University of Calgary, Alberta, Canada., Ashenhurst M; Department of Surgery, Division of Ophthalmology, Cumming School of Medicine, University of Calgary, Alberta, Canada., Hill V; Department of Surgery, Division of Ophthalmology, University of Calgary, Alberta, Canada., Jiang K; Department of Surgery, Division of Ophthalmology, Cumming School of Medicine, University of Calgary, Alberta, Canada. |
| Jazyk: |
angličtina |
| Zdroj: |
Journal of cutaneous medicine and surgery [J Cutan Med Surg] 2021 Sep; Vol. 25 (5), pp. 543-552. Date of Electronic Publication: 2021 Mar 02. |
| DOI: |
10.1177/1203475421999340 |
| Abstrakt: |
In the past few decades, minimally-invasive esthetic treatments and the use of injectable Hyaluronic Acid Gels and other filling agents to treat facial esthetics have increased dramatically. Although extremely rare, a filler can cause ocular and orbital ischemia by retrograde flow from the ophthalmic artery when injected in any of the anastomosis of the face. Once filler reaches the central retinal artery, blindness is inevitable, and no treatment is effective. While the risk of blindness happening with any filler injection is rare, the life-altering irreversible consequence of a procedure that was anticipated to be simple and beautifying is a reality that each injector must be prepared for with every injection. The parameters associated with an iatrogenic stroke of the eye are the site of injection, the injection technique, patient characteristics, and the material injected. Understanding the interplay of each of these variables might help us reduce the possibility of blindness during the injection of a soft-tissue cosmetic filler. Here, we explore the causes of Hyaluronic Acid Gels Filler embolic phenomena, review the natural course of the process, and discuss appropriate immediate interventions. We also (1) propose an education plan for injectors and describe how to carry out a focused ophthalmologic examination and procedural activities for a referral to an ophthalmologist, (2) outline steps to prevent emboli during filler injection, and (3) how to manage and support a patient with a sudden loss of vision during or immediately after a Hyaluronic Acid Gels filler treatment. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
